Puma Biotechnology, Inc. (PBYI) vs Sight Sciences, Inc. (SGHT)
A side-by-side comparison of Puma Biotechnology, Inc. and Sight Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PBYI
Puma Biotechnology, Inc.
$9.56HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
SGHT
Sight Sciences, Inc.
$8.61HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — PBYI vs SGHT
growth of $100 · dividends reinvested · last 5yPBYI +18.1% (+3.4%/yr)SGHT -73.4% (-23.3%/yr)PBYI compounded faster over this window
PBYI SGHT
PBYI vs SGHT: by the numbers
- •PBYI is the larger company ($486M vs $468M market cap).
- •PBYI is profitable (11.55% net margin) while SGHT runs a net loss (-35.69%).
- •SGHT grew revenue faster over the past five years (16.53% vs 0.29% CAGR).
Metrics side by side
Valuation
| Metric | PBYI | SGHT |
|---|---|---|
| P/E ratio | 18.51 | N/A |
| Forward P/E | 25.15 | N/A |
| P/S ratio | 2.10 | 5.62 |
| P/B ratio | 3.51 | 8.86 |
| EV / EBITDA | 10.47 | N/A |
| FCF yield | 8.45% | N/A |
Profitability
| Metric | PBYI | SGHT |
|---|---|---|
| Gross margin | 74.83% | 87.96% |
| Operating margin | 13.16% | -47.95% |
| Net margin | 11.55% | -35.69% |
| ROE | 19.28% | -56.26% |
| ROIC | 18.26% | -29.50% |
Growth (annualized)
| Metric | PBYI | SGHT |
|---|---|---|
| Revenue CAGR (5Y) | 0.29% | 16.53% |
| FCF CAGR (5Y) | 90.51% | N/A |
| Total return CAGR (5Y) | 9.26% | -18.69% |
Frequently asked
- Which has grown faster, PBYI or SGHT?
- Over the past five years, SGHT grew revenue faster — PBYI at a 0.29% CAGR versus SGHT at 16.53%.
- Is PBYI or SGHT more profitable?
- PBYI runs the higher net margin — PBYI at 11.55% versus SGHT at -35.69%.
- How have PBYI and SGHT total returns compared?
- Over the past 5 years, PBYI delivered 9.26% and SGHT delivered -18.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Puma Biotechnology P/E ratioPuma Biotechnology ROESight Sciences ROEPuma Biotechnology operating marginSight Sciences operating marginPuma Biotechnology revenue growthSight Sciences revenue growthPuma Biotechnology free cash flowSight Sciences free cash flow
Puma Biotechnology & Sight Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.